Monoclonal Antibodies against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine.


The large number of mutations identified across all cancers represents an untapped reservoir of targets that can be useful for therapeutic targeting if highly selective, mutation-specific reagents are available. We report here our attempt to generate such reagents: monoclonal antibodies against the most common R175H, R248Q, and R273H hotspot mutants of the… (More)
DOI: 10.1016/j.celrep.2017.11.112


  • Presentations referencing similar topics